Literature DB >> 26980230

Intramuscular versus intravenous prophylactic oxytocin for postpartum hemorrhage after vaginal delivery: a randomized controlled study.

Hediye Dagdeviren1, Huseyin Cengiz2, Ulkar Heydarova2, Sema Suzen Caypinar2, Ammar Kanawati2, Ender Guven2, Murat Ekin2.   

Abstract

PURPOSE: Prevention of postpartum haemorrhage (PPH) is essential in the pursuit of improved health care for women. Oxytocin, the most commonly used uterotonic agent to prevent PPH, has no established the route of administration. In this study we aimed to compare whether the mode of oxytocin administration, i.e., intravenous and intramuscular administration, has an effect on the potential benefits and side effects.
MATERIALS AND METHODS: A total of 256 women were randomised into two groups: intramuscular group (128) or intravenous group (128).
RESULTS: Estimated blood loss during the third stage of labour was similar between the two groups (p = 0.572). Further there were no statistically significant difference was noted between the two groups in terms of the mean duration of labor, duration of the third stage of labor, manual removal of the placenta, need for instrumental delivery, need for blood transfusion, PPH ≥500 mL, PPH ≥1000 mL, or length of hospital stay.
CONCLUSION: Using oxytocin by intravenous and intramuscular route has a similar efficacy and adverse effects.

Entities:  

Keywords:  Oxytocin; Postpartum haemorrhage; Randomized controlled trial; Vaginal delivery

Mesh:

Substances:

Year:  2016        PMID: 26980230     DOI: 10.1007/s00404-016-4060-7

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

Review 1.  Side-effects of oxytocin in postpartum hemorrhage: a systematic review and meta-analysis.

Authors:  Yanfei Zeng; Yinghui Zhang; Manhua Zhen; Li Lao; Yubo Ma; Li Liu; Dazhi Fan; Wen Ai
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour.

Authors:  Olufemi T Oladapo; Babasola O Okusanya; Edgardo Abalos; Ioannis D Gallos; Argyro Papadopoulou
Journal:  Cochrane Database Syst Rev       Date:  2020-11-09

3.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Argyro Papadopoulou; Rebecca Man; Nikolaos Athanasopoulos; Aurelio Tobias; Malcolm J Price; Myfanwy J Williams; Virginia Diaz; Julia Pasquale; Monica Chamillard; Mariana Widmer; Özge Tunçalp; G Justus Hofmeyr; Fernando Althabe; Ahmet Metin Gülmezoglu; Joshua P Vogel; Olufemi T Oladapo; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

4.  Variability of Clinical Practice in the Third Stage of Labour in Spain.

Authors:  Inmaculada Ortiz-Esquinas; Juan Gómez-Salgado; Ana I Pascual-Pedreño; Julián Rodríguez-Almagro; Juan Miguel Martínez-Galiano; Antonio Hernández-Martínez
Journal:  J Clin Med       Date:  2019-05-09       Impact factor: 4.241

5.  Postpartum haemorrhage (PPH) rates in randomized trials of PPH prophylactic interventions and the effect of underlying participant PPH risk: a meta-analysis.

Authors:  Lydia Hawker; Andrew Weeks
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-13       Impact factor: 3.007

Review 6.  Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour.

Authors:  Olufemi T Oladapo; Babasola O Okusanya; Edgardo Abalos
Journal:  Cochrane Database Syst Rev       Date:  2018-09-22

Review 7.  Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Authors:  Ioannis D Gallos; Helen M Williams; Malcolm J Price; Abi Merriel; Harold Gee; David Lissauer; Vidhya Moorthy; Aurelio Tobias; Jonathan J Deeks; Mariana Widmer; Özge Tunçalp; Ahmet Metin Gülmezoglu; G Justus Hofmeyr; Arri Coomarasamy
Journal:  Cochrane Database Syst Rev       Date:  2018-04-25

8.  Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial.

Authors:  Nita Adnan; Rebecca Conlan-Trant; Ciara McCormick; Fiona Boland; Deirdre J Murphy
Journal:  BMJ       Date:  2018-09-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.